Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Swain

Showing results (51-60 of 222) with videos related to

Pageof 23
Sort By:
Hepatology (Baltimore, Md.)|September 1, 1993
Plasma endopeptidase 24.11 (enkephalinase) activity is markedly increased in cholestatic liver diseaseM G Swain, J Vergalla, E A Jones
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 27, 2024
Cholestatic liver disease leads to significant adaptative changes in neural circuits regulating social behavior in mice to enhance sociabilityWagdi Almishri, Mohammed O Altonsy, Mark G Swain
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 15, 2001
Decreased orexigenic response to neuropeptide Y in rats with obstructive cholestasisK P Rioux, T Le, M G Swain
Gastroenterology|May 1, 1997
Impaired neutrophil microbicidal activity in rat cholestasisK Tjandra, R C Woodman, M G Swain
Biochemical Pharmacology|April 19, 2002
Chemokines as novel therapeutic targets in inflammatory diseasesMaureen N Ajuebor, Mark G Swain, Mauro Perretti
Alimentary Pharmacology & Therapeutics|February 1, 1990
Rapid intravenous low-dose diazepam as sedation for upper gastrointestinal endoscopyD G Swain, D J Ellis, H Bradby
Gastroenterology|March 5, 2002
Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic ratsKelly W Burak, Tai Le, Mark G Swain
Alimentary Pharmacology & Therapeutics|August 22, 2006
Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapyM A Babatin, F M Sanai, M G Swain
Arthritis and Rheumatism|July 1, 1995
End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiencyR J Hilsden, S J Urbanski, M G Swain
Journal of Clinical Pathology|March 1, 1993
Is serum creatine kinase:aspartate aminotransferase ratio useful for diagnosing acute myocardial infarction in elderly patients?D G Swain, R M Gama, P G Nightingale
Pageof 23

Showing results (51-60 of 222) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|September 1, 1993
Plasma endopeptidase 24.11 (enkephalinase) activity is markedly increased in cholestatic liver diseaseM G Swain, J Vergalla, E A Jones
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 27, 2024
Cholestatic liver disease leads to significant adaptative changes in neural circuits regulating social behavior in mice to enhance sociabilityWagdi Almishri, Mohammed O Altonsy, Mark G Swain
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 15, 2001
Decreased orexigenic response to neuropeptide Y in rats with obstructive cholestasisK P Rioux, T Le, M G Swain
Gastroenterology|May 1, 1997
Impaired neutrophil microbicidal activity in rat cholestasisK Tjandra, R C Woodman, M G Swain
Biochemical Pharmacology|April 19, 2002
Chemokines as novel therapeutic targets in inflammatory diseasesMaureen N Ajuebor, Mark G Swain, Mauro Perretti
Alimentary Pharmacology & Therapeutics|February 1, 1990
Rapid intravenous low-dose diazepam as sedation for upper gastrointestinal endoscopyD G Swain, D J Ellis, H Bradby
Gastroenterology|March 5, 2002
Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic ratsKelly W Burak, Tai Le, Mark G Swain
Alimentary Pharmacology & Therapeutics|August 22, 2006
Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapyM A Babatin, F M Sanai, M G Swain
Arthritis and Rheumatism|July 1, 1995
End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiencyR J Hilsden, S J Urbanski, M G Swain
Journal of Clinical Pathology|March 1, 1993
Is serum creatine kinase:aspartate aminotransferase ratio useful for diagnosing acute myocardial infarction in elderly patients?D G Swain, R M Gama, P G Nightingale
Pageof 23